Elevations in cerebrospinal fluid tau and/or TDP-43 have been widely documented and suggested as potential biomarkers for ALS although for the former these have in general reflected total tau (119, 120). The gene discussed is MAPT; the disease is amyotrophic lateral sclerosis.